-
-
-
The role of intensive antiplatelet therapy for prevention of vascular events in patients with atrial fibrillation remains controversial. The Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE) trio of studies is an attempt to clarify this issue.
-
A randomized study of treatment of septic arthritis in children 3 months to 15 years of age demonstrated that 10 days of treatment, with an initial 2-4 days intravenously followed by oral therapy, was sufficient for most cases, regardless of the infecting pathogen or site of infection.
-
-
Adenovirus 14 (Ad14) has emerged as a cause of febrile respiratory illness (FRI) and has resulted in pneumonia in a significant number of patients.
-
The combination of aspirin with clopidogrel is better than aspirin alone in reducing the risk of stroke in patients with atrial fibrillation.
-
The differential diagnosis of acute chest pain includes three entities that can be lethal if missed: myocardial infarction (MI), pulmonary embolus, and aortic dissection.
-
With more hospitals in recent years considering mandatory seasonal flu immunizations for health care workers, the rise and highly anticipated seasonal resurgence of H1N1 influenza A raises a compelling question: Will the first pandemic in 41 years add momentum to increasing calls to make flu immunization a condition of health care employment?
-
Timsit et al conducted a 2x2 randomized, controlled trial comparing chlorhexidine-impregnated sponges in the dressing of vascular catheters with control dressings.
